Inventor · disambiguated record
Jean-Francois Deleuze
Also filed as: DELEUZE JEAN-FRANCOIS · DELEUZE JEAN-FRANÇOIS
10 granted patents·10 pending applications·0 citations·filing 2003–2022
79Inventor score
Files withSANOFI AVENTIS DEUTSCHLAND8KOZIAN DETLEF4GENZYME CORP3AVENTIS PHARMA GMBH1AVENTIS PHARMA SA1
Top patents by PatentIndex Score
20 records- 0173US7892744B2Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disordersSANOFI AVENTIS DEUTSCHLAND·Filed 2009·Granted Feb 22, 2011·0 cites·6 claims
- 0269US2022409595A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2022·Application pending·0 cites
- 0367US7888020B2Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereofSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Granted Feb 15, 2011·0 cites·1 claims
- 0461US7262273B2Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereofSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Aug 28, 2007·0 cites·1 claims
- 0561US2012208200A1Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereofKOZIAN DETLEF·Filed 2012·Application pending·0 cites
- 0659US8198022B2Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereofKOZIAN DETLEF·Filed 2011·Granted Jun 12, 2012·0 cites·1 claims
- 0759US7785781B2Method of diagnosis of a predisposition to develop thrombotic disease and its usesSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Aug 31, 2010·0 cites·9 claims
- 0855US2016361301A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Application pending·0 cites
- 0954US8420321B2Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphismKOZIAN DETLEF·Filed 2011·Granted Apr 16, 2013·0 cites·3 claims
- 1053US7803538B2Method for detecting Alzheimer's diseaseAVENTIS PHARMA SA·Filed 2004·Granted Sep 28, 2010·0 cites·7 claims
- 1153US2005019795A1Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disordersAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 1251US7560290B2Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphismSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Jul 14, 2009·0 cites·9 claims
- 1351US2010221738A1Method of diagnosis of a predisposition to develop thrombotic disease and its usesSANOFI AVENTIS DEUTSCHLAND·Filed 2010·Application pending·0 cites
- 1451US2019046509A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2018·Application pending·0 cites
- 1550US8084198B2Use of a GIP promoter polymorphismKOZIAN DETLEF·Filed 2006·Granted Dec 27, 2011·0 cites·9 claims
- 1646US2007292859A1Association of Protein Polymorphisms With Coronary Heart DiseaseSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Application pending·0 cites
- 1745US2010062431A1Use of adamts4 gene and protein polymorphismsSANOFI AVENTIS·Filed 2007·Application pending·0 cites
- 1837US7985562B2Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphismSANOFI AVENTIS DEUTSCHLAND·Filed 2009·Granted Jul 26, 2011·0 cites·9 claims
- 1931US2017216360A1Methods and compositions for improving homing of cells including mesenchymal stem cellsSANOFI SA·Filed 2015·Application pending·0 cites
- 2028US2013330341A1Single nucleotide polymorphisms in the promoter of vegfa gene and their use as predictive markers for anti-vegf treatmentsCHIRON BLONDEL MARIELLE·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean-Francois Deleuze files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →